Pharmabiz13h
ImmunoGenesis doses 1st patient in phase 1/2 trial of IMGS-101 in combo with balstilimab & zalifrelimab to treat immune-excluded tumours
ImmunoGenesis doses 1st patient in phase 1/2 trial of IMGS-101 in combo with balstilimab & zalifrelimab to treat immune-excluded tumours: Houston Saturday, March 8, 2025, 18:00 Hr ...
Pharmabiz14h
Beneq & Exosens collaborate on lead-free MCPs with ALD, enhancing precision, performance, and manufacturing efficiency
Beneq & Exosens collaborate on lead-free MCPs with ALD, enhancing precision, performance, and manufacturing efficiency: Espoo, Finland Saturday, March 8, 2025, 17:00 Hrs [IST] Ben ...
Pharmabiz16h
Hutchmed completes enrollment in phase II registration study of fanregratinib for intrahepatic cholangiocarcinoma in China
Hutchmed completes enrollment in phase II registration study of fanregratinib for intrahepatic cholangiocarcinoma in China: Hong Kong, Shanghai Saturday, March 8, 2025, 15:00 Hrs ...
Pharmabiz17h
GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults
GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...
Pharmabiz18h
Everest Medicines doses first patient in its internally developed personalized mRNA cancer vaccine, EVM16
Everest Medicines doses first patient in its internally developed personalized mRNA cancer vaccine, EVM16: Shanghai, China Saturday, March 8, 2025, 13:00 Hrs [IST] Everest Medicin ...
Pharmabiz19h
WHO announces new collaborating centre on artificial intelligence for health governance
WHO announces new collaborating centre on artificial intelligence for health governance: Geneva Saturday, March 8, 2025, 12:00 Hrs [IST] The World Health Organization (WHO) design ...
Pharmabiz21h
Roche launches Roche Genentech Innovation Center Boston at Harvard’s Enterprise Research Campus in Allston
Roche, announced the launch of the Roche Genentech Innovation Center Boston at Harvard’s Enterprise Research Campus in Allston which will further strengthen the long-standing partnership in areas such ...
Pharmabiz22h
Lupin introduces rivaroxaban tablets USP, 2.5mg in US
Global pharma major Lupin Limited (Lupin) announced that it has launched rivaroxaban tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application from the US FDA.
Pharmabiz22h
IISc to host Longevity India Conference – Rise for Healthy Aging from March 10 to 12, 2025 in Bengaluru
IISc to host Longevity India Conference – Rise for Healthy Aging from March 10 to 12, 2025 in Bengaluru: Our Bureau, Bengaluru Saturday, March 8, 2025, 09:00 Hrs [IST] Indian In ...
Pharmabiz23h
IRGMA exposes flooding of substandard & illegally imported low quality non-medical gloves in Indian hospitals
IRGMA exposes flooding of substandard & illegally imported low quality non-medical gloves in Indian hospitals: Nandita Vijayasimha, Bengaluru Saturday, March 8, 2025, 08:00 Hrs [I ...
Pharmabiz23h
Telangana DCA initiates action against distributor for violation of medication storage norms
Telangana DCA initiates action against distributor for violation of medication storage norms: Peethaambaran Kunnathoor, Chennai Saturday, March 8, 2025, 08:00 Hrs [IST] As part of ...
Pharmabiz23h
Karnataka govt gives a booster dose to hospital infrastructure by investing Rs. 1,182 crore
Karnataka govt gives a booster dose to hospital infrastructure by investing Rs. 1,182 crore: Nandita Vijayasimha, Bengaluru Saturday, March 8, 2025, 08:00 Hrs [IST] The Karnataka ...